Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic

Chung-Jen Chen1, Sabrina Bakeera-Kitaka2, Ezekiel Mupere2

  • 1Department of Pediatrics, Columbia University Medical Center, New York, New York, United States.

Insights

Recommended vaccinations and preventative medications for children with sickle cell disease (SCD) in Uganda were often incomplete and delayed. Improved clinic oversight is needed to ensure timely uptake of essential care for SCD patients.

Area of Science:

  • Pediatrics
  • Hematology
  • Public Health

Background:

  • Sickle cell disease (SCD) requires comprehensive care, including vaccinations and prophylactic medications, to prevent serious complications in young children.
  • Assessing the quality of care for SCD patients in resource-limited settings is crucial for identifying gaps and improving health outcomes.

Purpose of the Study:

  • To evaluate the receipt of recommended vaccinations and prophylactic treatments for children under 71 months with SCD at a central clinic in Kampala, Uganda.
  • To identify factors associated with the timely and complete administration of these essential preventative measures.

Main Methods:

  • A cross-sectional study was conducted at Mulago Hospital SCD Clinic, reviewing immunization cards and clinic records.
  • Data on vaccination status, timeliness, and prescribed antibacterial and antimalarial prophylaxis were collected for children with SCD aged ≤71 months.

Main Results:

  • Only 46.2% of children received all recommended vaccine doses, with lower completion rates for pneumococcal 10-valent conjugate vaccine (PCV-10) in older children (18.2% for ages 48-71 months).
  • Timely vaccination (<60 days late) was achieved in only 68.8% of fully vaccinated children, with just 13.5% being both fully and timely vaccinated.
  • While 81.6% had documented prescriptions for penicillin and/or antimalarial prophylaxis, adherence and completeness were not detailed.

Conclusions:

  • Preventative care, including vaccinations (especially PCV-10) and chemoprophylaxis, was incomplete and often delayed for young children with SCD at this Ugandan clinic.
  • Child age was associated with vaccination and chemoprophylaxis receipt, but not general maternal demographics.
  • Enhanced clinic-based oversight is recommended to improve the timely uptake of these critical preventative health measures for children with SCD.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
653
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
945
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
587
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
438
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
596